Thrisoint Pty Ltd provides a new dimension in the approach to healthcare and longevity.

The non-invasive Electro Pressure Regeneration Therapy (EPRT) technology utilizes ultra low frequencies to treat the patient at a cellular level and correct the source of the health issue.

Thrisoint Pty. Ltd. distributes and markets the Bodihealth TENS System internationally.

The BodiHealth TENS System has U.S. FDA 510(K) no. K052836 clearance to market in the U.S., CE Mark Certification No. 41316067, and TGA (Therapeutic Goods Administration) Registration in Australia, inclusion number ARTG No. 152316. 

FDA 510(K) indications for use: 

"The EPRT BodiHealth device is intended for temporary symptomatic relief and management of chronic intractable pain and as an adjunctive treatment in the management of post surgical and post traumatic pain".

TGA Registration indications for use:

"Stimulator, electrical, analgesic, peripheral nerve, transcutaneous.  This device is used to treat pain associated with surgery, trauma, musculoskeletal problems, bursits or dental problems.  It is also used in physical therapy and during labor/delivery."